Home ETF List About

Portfolio Holdings Detail for ISIN IE00BFNM3G45
Stock Name / FundiShares MSCI USA ESG Screened UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerSASU(USD) LSE
ETF TickerGPSA(GBP) LSE
ETF TickerSGAS(EUR) F
ETF TickerGPSA.LS(GBP) CXE
ETF TickerSASU.LS(USD) CXE
ETF TickerSASUz(USD) CXE
ETF TickerSGAS.DE(EUR) CXE
ETF TickerSASU.L(GBP) LSE
ETF TickerGPSA.L(GBP) LSE

Holdings detail for SOLV

Stock NameSolventum Corp.
TickerSOLV(USD) NYSE
TYPECommon Stock
CountryUSA
ISINUS83444M1018

Show aggregate SOLV holdings

News associated with SOLV

Wells Fargo & Company Issues Positive Forecast for Solventum (NYSE:SOLV) Stock Price
Solventum (NYSE:SOLV – Get Free Report) had its price target upped by equities researchers at Wells Fargo & Company from $79.00 to $82.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price target suggests a potential upside of […] - 2025-09-17 03:06:58
Solventum Completes Sale Of Purification & Filtration Business; Raises Annual Earnings Outlook
(RTTNews) - Solventum Corporation (SOLV) Tuesday said that it has completed the sale of its Purification & Filtration business to Thermo Fisher Scientific Inc. (TMO) for $4 billion in cash. - 2025-09-02 10:10:37
Solventum (NYSE:SOLV) Rating Increased to Strong-Buy at Wall Street Zen
Solventum (NYSE:SOLV – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a report issued on Monday. Several other equities research analysts have also issued reports on SOLV. KeyCorp started coverage on Solventum in a report on Friday, June 6th. They set a […] - 2025-09-01 03:10:44
Solventum (NYSE:SOLV) Stock Rating Lowered by Wall Street Zen
Solventum (NYSE:SOLV – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Sunday. A number of other brokerages have also recently commented on SOLV. Morgan Stanley upgraded shares of Solventum from an “equal weight” rating to […] - 2025-08-24 06:14:43
Solventum Corporation (NYSE:SOLV) Shares Sold by Maryland State Retirement & Pension System
Maryland State Retirement & Pension System lessened its stake in Solventum Corporation (NYSE:SOLV – Free Report) by 18.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 6,479 shares of the company’s stock after selling 1,439 shares during the quarter. Maryland State Retirement […] - 2025-08-15 04:51:01
Solventum Announces Pricing Of Secondary Offering Of 8.80 Mln Common Stock
(RTTNews) - Solventum Corp. (SOLV) announced the pricing of the secondary offering of 8.80 million shares of its common stock, which is expected to result in gross proceeds of about $648 million to 3M Company. All of the shares of common stock are being sold by the Selling Shareh - 2025-08-14 00:33:56
Solventum Corporation (NYSE:SOLV) Shares Purchased by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. boosted its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 2.2% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,173,960 shares of the company’s stock after buying an additional 24,762 shares during the quarter. Charles Schwab Investment Management […] - 2025-08-13 05:10:47
Blair William & Co. IL Sells 552 Shares of Solventum Corporation (NYSE:SOLV)
Blair William & Co. IL lessened its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 4.8% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 11,010 shares of the company’s stock after selling 552 shares during the period. Blair William & Co. IL’s holdings in Solventum were worth $837,000 at […] - 2025-08-11 06:24:58
Federated Hermes Inc. Trims Position in Solventum Corporation (NYSE:SOLV)
Federated Hermes Inc. trimmed its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 67.6% in the first quarter, Holdings Channel.com reports. The institutional investor owned 764 shares of the company’s stock after selling 1,595 shares during the quarter. Federated Hermes Inc.’s holdings in Solventum were worth $58,000 as of its most recent filing with […] - 2025-08-11 05:04:58
Solventum (NYSE:SOLV) Price Target Raised to $94.00
Solventum (NYSE:SOLV – Free Report) had its price objective upped by Piper Sandler from $87.00 to $94.00 in a research report sent to investors on Friday,Benzinga reports. The brokerage currently has an overweight rating on the stock. A number of other equities analysts also recently weighed in on the company. Morgan Stanley raised Solventum from […] - 2025-08-11 03:08:46
XTX Topco Ltd Grows Stock Position in Solventum Corporation (NYSE:SOLV)
XTX Topco Ltd lifted its position in Solventum Corporation (NYSE:SOLV – Free Report) by 26.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,417 shares of the company’s stock after purchasing an additional 1,356 shares during the quarter. XTX Topco Ltd’s […] - 2025-08-08 04:38:55
Noteworthy Thursday Option Activity: AKAM, EXPE, SOLV
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Akamai Technologies Inc (Symbol: AKAM), where a total of 8,566 contracts have traded so far, representing approximately 856,600 underlying shares. That amounts to about 5 - 2025-08-07 14:17:28
Financial Analysis: Solventum (NYSE:SOLV) and BG Medicine (OTCMKTS:BGMD)
BG Medicine (OTCMKTS:BGMD – Get Free Report) and Solventum (NYSE:SOLV – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership. Valuation & Earnings This table compares BG Medicine and […] - 2025-08-05 02:41:00
Solventum Corporation (NYSE:SOLV) Receives $84.38 Average Target Price from Brokerages
Shares of Solventum Corporation (NYSE:SOLV – Get Free Report) have earned an average rating of “Hold” from the eleven brokerages that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, six have given a hold recommendation and four have assigned a buy recommendation to the company. […] - 2025-08-01 02:50:51
Universal Beteiligungs und Servicegesellschaft mbH Buys 584 Shares of Solventum Corporation (NYSE:SOLV)
Universal Beteiligungs und Servicegesellschaft mbH increased its stake in Solventum Corporation (NYSE:SOLV – Free Report) by 1.1% during the 1st quarter, Holdings Channel reports. The firm owned 53,143 shares of the company’s stock after purchasing an additional 584 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Solventum were worth $4,041,000 at the […] - 2025-07-29 05:22:58
7,059 Shares in Solventum Corporation (NYSE:SOLV) Purchased by Y Intercept Hong Kong Ltd
Y Intercept Hong Kong Ltd acquired a new stake in Solventum Corporation (NYSE:SOLV – Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The fund acquired 7,059 shares of the company’s stock, valued at approximately $537,000. Several other institutional investors have also added to or reduced their stakes […] - 2025-07-28 06:02:51
New York State Common Retirement Fund Reduces Holdings in Solventum Corporation (NYSE:SOLV)
New York State Common Retirement Fund lowered its position in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 24.1% during the first quarter, Holdings Channel reports. The fund owned 67,549 shares of the company’s stock after selling 21,500 shares during the quarter. New York State Common Retirement Fund’s holdings in Solventum were worth $5,136,000 […] - 2025-07-22 07:09:10
Solventum Corporation (NYSE:SOLV) Shares Sold by Cwm LLC
Cwm LLC cut its holdings in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 13.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 15,875 shares of the company’s stock after selling 2,420 shares during the period. Cwm LLC’s holdings in Solventum […] - 2025-07-21 05:18:49
Cerity Partners LLC Buys 1,294 Shares of Solventum Corporation (NYSE:SOLV)
Cerity Partners LLC grew its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 2.8% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 47,466 shares of the company’s stock after buying an additional 1,294 shares during the quarter. Cerity Partners […] - 2025-07-18 04:55:04
Solventum Corporation (NYSE:SOLV) Shares Sold by Arizona State Retirement System
Arizona State Retirement System trimmed its holdings in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 0.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 42,466 shares of the company’s stock after selling 173 shares during the period. Arizona […] - 2025-07-17 05:51:11
Morgan Stanley Upgrades Solventum (NYSE:SOLV) to Overweight
Solventum (NYSE:SOLV – Get Free Report) was upgraded by research analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a research report issued on Tuesday, Marketbeat.com reports. The brokerage presently has a $103.00 target price on the stock, up from their prior target price of $80.00. Morgan Stanley’s price target […] - 2025-07-17 05:00:52
Solventum Corporation (NYSE:SOLV) Shares Sold by Stratos Wealth Partners LTD.
Stratos Wealth Partners LTD. lessened its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 50.6% in the 1st quarter, Holdings Channel reports. The firm owned 4,256 shares of the company’s stock after selling 4,355 shares during the period. Stratos Wealth Partners LTD.’s holdings in Solventum were worth $324,000 at the end of […] - 2025-07-16 04:58:53
Solventum Corporation (NYSE:SOLV) Shares Sold by D.A. Davidson & CO.
D.A. Davidson & CO. lowered its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 11.8% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 7,478 shares of the company’s stock after selling 1,002 shares during the period. D.A. Davidson & CO.’s holdings in Solventum were worth […] - 2025-07-11 05:26:54
Solventum Corporation (NYSE:SOLV) Receives $81.50 Average Price Target from Analysts
Shares of Solventum Corporation (NYSE:SOLV – Get Free Report) have been assigned an average rating of “Hold” from the eleven research firms that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to […] - 2025-07-07 02:06:56
Solventum Corporation (NYSE:SOLV) Position Lessened by Cambridge Investment Research Advisors Inc.
Cambridge Investment Research Advisors Inc. reduced its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 4.5% during the 1st quarter, HoldingsChannel reports. The firm owned 18,893 shares of the company’s stock after selling 895 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in Solventum were worth $1,437,000 as of its most recent […] - 2025-07-04 04:32:51
Sumitomo Mitsui Trust Group Inc. Sells 586 Shares of Solventum Corporation (NYSE:SOLV)
Sumitomo Mitsui Trust Group Inc. reduced its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 0.2% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 319,689 shares of the company’s stock after selling 586 shares during the period. Sumitomo Mitsui Trust Group Inc.’s holdings in Solventum were worth $24,309,000 at the end of […] - 2025-07-03 05:35:09
Robeco Institutional Asset Management B.V. Purchases 2,544 Shares of Solventum Corporation (NYSE:SOLV)
Robeco Institutional Asset Management B.V. lifted its position in Solventum Corporation (NYSE:SOLV – Free Report) by 8.9% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 31,238 shares of the company’s stock after purchasing an additional 2,544 shares during the quarter. Robeco Institutional Asset Management […] - 2025-07-02 06:14:53
Mirae Asset Global Investments Co. Ltd. Decreases Position in Solventum Corporation (NYSE:SOLV)
Mirae Asset Global Investments Co. Ltd. cut its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 5.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 56,617 shares of the company’s stock after selling 3,174 shares […] - 2025-07-02 05:35:01
Perigon Wealth Management LLC Acquires 159 Shares of Solventum Corporation (NYSE:SOLV)
Perigon Wealth Management LLC raised its holdings in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 3.8% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,352 shares of the company’s stock after acquiring an additional 159 shares during the quarter. Perigon Wealth […] - 2025-07-01 05:09:18
Solventum Corporation (NYSE:SOLV) Shares Purchased by Sequoia Financial Advisors LLC
Sequoia Financial Advisors LLC increased its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 137.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,344 shares of the company’s stock after purchasing an additional 10,027 shares during the quarter. […] - 2025-06-30 06:10:48

iShares MSCI USA ESG Screened UCITS ETF USD (Acc) SOLV holdings

DateNumber of SOLV Shares HeldBase Market Value of SOLV SharesLocal Market Value of SOLV SharesChange in SOLV Shares HeldChange in SOLV Base ValueCurrent Price per SOLV Share HeldPrevious Price per SOLV Share Held
2025-09-18 (Thursday)41,595SOLV holding increased by 108USD 3,093,420SOLV holding increased by 20478USD 3,093,420108USD 20,478 USD 74.37 USD 74.07
2025-09-17 (Wednesday)41,487SOLV holding increased by 135USD 3,072,942SOLV holding increased by 7518USD 3,072,942135USD 7,518 USD 74.07 USD 74.13
2025-09-16 (Tuesday)41,352SOLV holding increased by 216USD 3,065,424SOLV holding increased by 53857USD 3,065,424216USD 53,857 USD 74.13 USD 73.21
2025-09-15 (Monday)41,136USD 3,011,567USD 3,011,567
2025-09-12 (Friday)41,064USD 3,013,687USD 3,013,687
2025-09-11 (Thursday)41,064USD 3,030,113USD 3,030,113
2025-09-10 (Wednesday)41,073USD 2,925,219USD 2,925,219
2025-09-09 (Tuesday)40,497USD 2,952,231USD 2,952,231
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of SOLV by Blackrock for IE00BFNM3G45

Show aggregate share trades of SOLV

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-18BUY108 74.370* 72.79
2025-09-17BUY135 74.070* 72.79
2025-09-16BUY216 74.130* 72.78
2025-08-15BUY18 71.420* 72.80
2025-08-13BUY10 74.380* 72.79
2025-07-31BUY45 71.360* 72.80
2025-07-29BUY180 73.550* 72.80
2025-07-28BUY36 73.770* 72.79
2025-07-25BUY54 74.750* 72.78
2025-07-24BUY26 73.930* 72.77
2025-07-23BUY63 74.400* 72.76
2025-07-22BUY36 72.920* 72.76
2025-07-18BUY64 73.280* 72.76
2025-07-17BUY54 73.860* 72.75
2025-07-07SELL-54 76.240* 72.70 Profit of 3,926 on sale
2025-07-02SELL-242 78.250* 72.59 Profit of 17,568 on sale
2025-06-27BUY32 75.460* 72.56
2025-06-26BUY27 74.630* 72.54
2025-06-24SELL-126 74.980* 72.51 Profit of 9,136 on sale
2025-06-18BUY72 72.630* 72.50
2025-06-17BUY27 72.760* 72.49
2025-06-16SELL-37 74.450* 72.48 Profit of 2,682 on sale
2025-06-13BUY84 73.800* 72.47
2025-06-12SELL-45 74.290* 72.46 Profit of 3,261 on sale
2025-06-11BUY107 74.410* 72.45
2025-06-06BUY27 74.840* 72.39
2025-06-05BUY126 75.370* 72.37
2025-06-04BUY18 75.140* 72.35
2025-06-03SELL-9 74.260* 72.33 Profit of 651 on sale
2025-05-30SELL-1,098 73.090* 72.32 Profit of 79,411 on sale
2025-05-29BUY23 72.610* 72.32
2025-05-27BUY153 72.530* 72.32
2025-05-23BUY120 70.810* 72.34
2025-05-22BUY63 72.660* 72.34
2025-05-19BUY54 75.770* 72.29
2025-05-16BUY27 74.110* 72.27
2025-05-15SELL-18 72.940* 72.27 Profit of 1,301 on sale
2025-05-14BUY9 71.140* 72.28
2025-05-13BUY18 73.520* 72.27
2025-05-12BUY58 74.800* 72.25
2025-05-09SELL-45 70.230* 72.26 Profit of 3,252 on sale
2025-05-08BUY18 66.630* 72.31
2025-05-07BUY27 65.490* 72.37
2025-05-02BUY999 67.620* 72.52
2025-04-30BUY315 66.120* 72.63
2025-04-29BUY78 66.250* 72.69
2025-04-28BUY63 66.070* 72.75
2025-04-25BUY162 66.070* 72.81
2025-04-24SELL-189 67.530* 72.86 Profit of 13,770 on sale
2025-04-23BUY171 65.900* 72.92
2025-04-22BUY72 64.940* 72.99
2025-04-17BUY99 66.260* 73.21
2025-04-15BUY90 65.930* 73.35
2025-04-11BUY144 66.190* 73.48
2025-04-09BUY54 68.580* 73.61
2025-04-08BUY324 63.010* 73.72
2025-04-07BUY105 65.320* 73.81
2025-04-04SELL-144 66.200* 73.89 Profit of 10,640 on sale
2025-04-02BUY1,224 76.620* 73.86
2025-04-01BUY9 76.340* 73.83
2025-03-31BUY63 76.040* 73.81
2025-03-28BUY36 74.750* 73.80
2025-03-27BUY16 75.510* 73.78
2025-03-26BUY9 74.240* 73.77
2025-03-25BUY99 74.930* 73.76
2025-03-24BUY104 74.200* 73.75
2025-03-21SELL-36 73.970* 73.75 Profit of 2,655 on sale
2025-03-20BUY144 74.990* 73.74
2025-03-19BUY24 76.310* 73.71
2025-03-18BUY304 75.300* 73.69
2025-03-17BUY63 75.150* 73.67
2025-03-14BUY468 74.160* 73.66
2025-03-13BUY90 72.300* 73.68
2025-03-12SELL-450 74.010* 73.68 Profit of 33,155 on sale
2025-03-11SELL-333 75.890* 73.65 Profit of 24,525 on sale
2025-03-10BUY99 77.640* 73.60
2025-03-07BUY18 77.930* 73.54
2025-03-05BUY135 77.830* 73.49
2025-03-04BUY153 78.990* 73.41
2025-03-03BUY288 80.160* 73.32
2025-02-28BUY234 79.750* 73.23
2025-02-27SELL-45 83.440* 73.09 Profit of 3,289 on sale
2025-02-25BUY333 83.560* 72.79
2025-02-21BUY36 73.020* 72.73
2025-02-18SELL-81 74.340* 72.66 Profit of 5,885 on sale
2025-02-14SELL-549 74.240* 72.61 Profit of 39,862 on sale
2025-02-13BUY9 74.310* 72.58
2025-02-12BUY88 73.680* 72.56
2025-02-07SELL-14 73.380* 72.50 Profit of 1,015 on sale
2025-02-06BUY171 74.780* 72.46
2025-02-05BUY45 74.790* 72.42
2025-02-04BUY54 74.610* 72.38
2025-02-03BUY54 73.580* 72.36
2025-01-31BUY99 74.060* 72.32
2025-01-29SELL-9 74.500* 72.22 Profit of 650 on sale
2025-01-28SELL-81 74.880* 72.17 Profit of 5,846 on sale
2025-01-27SELL-144 75.140* 72.11 Profit of 10,384 on sale
2025-01-24BUY108 74.990* 72.05
2025-01-23BUY18 73.600* 72.02
2024-12-10BUY450 69.720* 72.07
2024-12-09BUY54 70.630* 72.10
2024-12-06SELL-135 69.960* 72.15 Profit of 9,740 on sale
2024-12-05SELL-9 69.570* 72.21 Profit of 650 on sale
2024-12-03BUY45 70.770* 72.29
2024-11-27SELL-54 72.480* 72.31 Profit of 3,905 on sale
2024-11-26BUY189 71.490* 72.33
2024-11-25BUY24 71.610* 72.35
2024-11-22SELL-18 70.810* 72.40 Profit of 1,303 on sale
2024-11-21SELL-45 69.630* 72.48 Profit of 3,262 on sale
2024-11-20SELL-18 68.390* 72.61 Profit of 1,307 on sale
2024-11-19BUY9 67.050* 72.79
2024-11-18BUY80 67.120* 72.98
2024-11-11BUY27 71.530* 73.17
2024-11-11BUY27 71.530* 73.17
2024-11-07BUY27 75.070* 73.07
2024-11-07BUY27 75.070* 73.07
2024-11-06BUY216 74.140* 72.97
2024-11-06BUY216 74.140* 72.97
2024-11-05BUY45 73.160* 72.95
2024-11-05BUY45 73.160* 72.95
2024-11-04BUY18 72.170* 73.04
2024-11-04BUY18 72.170* 73.04
2024-11-01BUY27 72.460* 73.11
2024-11-01BUY27 72.460* 73.11
2024-10-30SELL-54 73.570* 73.13 Profit of 3,949 on sale
2024-10-30SELL-54 73.570* 73.13 Profit of 3,949 on sale
2024-10-29SELL-162 73.350* 73.08 Profit of 11,839 on sale
2024-10-29SELL-162 73.350* 73.08 Profit of 11,839 on sale
2024-10-28SELL-63 73.360* 73.00 Profit of 4,599 on sale
2024-10-28SELL-63 73.360* 73.00 Profit of 4,599 on sale
2024-10-21SELL-9 73.100* 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of SOLV

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19179,6991247,01572.7%
2025-09-18190,93029298,08864.1%
2025-09-17498,6723687,70572.5%
2025-09-16228,165327380,92959.9%
2025-09-15554,89912778,87471.2%
2025-09-12588,13632828,29371.0%
2025-09-11246,9841766,54132.2%
2025-09-10188,827332335,56456.3%
2025-09-09188,522332341,42855.2%
2025-09-08365,458198631,15357.9%
2025-09-05127,61129238,25053.6%
2025-09-04156,465248253,84361.6%
2025-09-03159,378103300,28253.1%
2025-09-02159,60986281,26256.7%
2025-08-29113,32429255,67244.3%
2025-08-28190,310320342,93655.5%
2025-08-27156,02590316,14649.4%
2025-08-26123,604121173,81171.1%
2025-08-25156,1157260,24160.0%
2025-08-22240,180367380,07963.2%
2025-08-21140,496278208,89267.3%
2025-08-20154,256530300,20351.4%
2025-08-19141,00824317,43144.4%
2025-08-18272,5350526,91751.7%
2025-08-15397,918956744,78953.4%
2025-08-14785,818571,905,07941.2%
2025-08-13139,646264281,31249.6%
2025-08-1275,373138215,21035.0%
2025-08-11132,362550245,32754.0%
2025-08-08354,273107703,52250.4%
2025-08-07343,61845670,94451.2%
2025-08-06174,8056282,65761.8%
2025-08-05167,8260258,80264.8%
2025-08-04184,021466312,37558.9%
2025-08-01157,693108263,71559.8%
2025-07-31101,7588215,51047.2%
2025-07-3082,277230159,10351.7%
2025-07-2954,40929136,96039.7%
2025-07-2875,6080149,49950.6%
2025-07-2586,7330172,97050.1%
2025-07-2480,110112147,49954.3%
2025-07-2371,97091163,99143.9%
2025-07-2287,106348175,00649.8%
2025-07-2168,91526139,86949.3%
2025-07-1874,959145166,55545.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.